A sprawling institutional structure has been created in the 38 years since the parliament legislated the framework that explicitly excluded patients from PBS decision-making. It took 11 years to add one consumer representative and another 17 years to add a second. It is the definition of an afterthought, but why would anyone be surprised?
Patients do not live their condition as aggregated economic models
January 14, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Arthritis Australia unveils new grants and identity as research breakthroughs loom
July 16, 2026 - - Latest News -
Organon and Samsung Bioepis expand partnership to broaden biosimilar access in Australia
July 16, 2026 - - Latest News -
A single payer system in which the worst kind of inequity is the only one permitted
July 16, 2026 - - Latest News -
Algorae names Nasdaq pharmaceutical chairman to strengthen board
July 15, 2026 - - Australian Biotech -
Starpharma raises $32 Million to advance dendrimer cancer programs
July 15, 2026 - - Australian Biotech -
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 - - Latest News -
Budget outlook now hangs on disability savings, but what about pharmaceuticals
July 15, 2026 - - Latest News

